XML 27 R15.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Balance Sheet Detail
9 Months Ended
Jul. 28, 2024
Balance Sheet Detail [Abstract]  
Balance Sheet Detail Balance Sheet Detail
 
July 28,
2024
October 29,
2023
 (In millions)
Inventories
Customer service spares$1,727 $1,589 
Raw materials1,688 1,653 
Work-in-process945 997 
Finished goods
Deferred cost of sales267 413 
Evaluation inventory487 423 
Manufactured on-hand inventory454 650 
Total finished goods1,208 1,486 
Total inventories$5,568 $5,725 

 
July 28,
2024
October 29,
2023
 (In millions)
Other Current Assets
Prepaid income taxes and income taxes receivable$51 $412 
Prepaid expenses and other979 976 
$1,030 $1,388 
Useful LifeJuly 28,
2024
October 29,
2023
 (In years)(In millions)
Property, Plant and Equipment, Net
Land and improvements$436 $393 
Buildings and improvements
3-30
2,314 2,194 
Demonstration and manufacturing equipment
5-8
2,573 2,353 
Furniture, fixtures and other equipment
3-5
806 762 
Construction in progress828 672 
Gross property, plant and equipment6,957 6,374 
Accumulated depreciation(3,857)(3,651)
$3,100 $2,723 


July 28,
2024
October 29,
2023
 (In millions)
Deferred Income Taxes and Other Assets
Non-current deferred income taxes$2,107 $1,729 
Operating lease right-of-use assets355 370 
Finance lease right-of-use assets91 108 
Income tax receivables and other assets348 345 
$2,901 $2,552 


July 28,
2024
October 29,
2023
 (In millions)
Accounts Payable and Accrued Expenses
Accounts payable$1,470 $1,478 
Compensation and employee benefits995 1,024 
Warranty347 332 
Dividends payable330 267 
Income taxes payable365 282 
Other accrued taxes74 65 
Interest payable59 38 
Operating lease liabilities, current86 84 
Finance lease liabilities, current89 102 
Other572 625 
$4,387 $4,297 
 
 
July 28,
2024
October 29,
2023
 (In millions)
Other Liabilities
Defined and postretirement benefit plans$121 $126 
Operating lease liabilities, non-current239 252 
Other390 336 
$750 $714 

Government Assistance
We receive government assistance from various domestic and foreign governments in the form of cash grants or refundable tax credits. These arrangements incentivize capital investments and research and development activities. Government incentives generally contain conditions that must be met in order for the assistance to be earned. We recognize the incentives when there is reasonable assurance that we will comply with all conditions specified in the incentive arrangement and the incentive will be received.
We record capital expenditure related incentives as an offset to the associated property, plant and equipment, net within our Consolidated Condensed Balance Sheets and recognize a reduction to depreciation expense over the useful life of the corresponding acquired asset. We record incentives related to operating activities as a reduction to expense in the same line item on the Consolidated Condensed Statements of Operations as the expenditure for which the grant is intended to compensate. Capital expenditure related incentives reduced gross property, plant and equipment, net by $279 million as of July 28, 2024. Contra-depreciation expense was not material during the three and nine months ended July 28, 2024. Operating incentives recognized as a reduction to research, development and engineering expense were $10 million and $32 million in the three and nine months ended July 28, 2024, respectively. Capital expenditure related incentives reduced our income taxes payable by $112 million as of July 28, 2024, of which $105 million is in accounts payable and accrued expenses and $7 million is in income taxes payable, in our Consolidated Condensed Balance Sheets.